ClinicalTrials.Veeva

Menu

Comparison of the Effect of Montelukast and Cetirizine on Allergic Inflammation in Children With Allergic Rhinitis

M

Medical University of Lodz

Status and phase

Unknown
Phase 4

Conditions

Seasonal Allergic Rhinitis

Treatments

Drug: placebo
Drug: montelukast
Drug: cetirizine
Drug: montelukast and cetirizine

Study type

Interventional

Funder types

Other

Identifiers

NCT00488176
RNN/94/07KE

Details and patient eligibility

About

The aim of this study is to compare the effect of montelukast and cetirizine on allergic inflammation measured by exhaled nitric oxide concentration in children with seasonal allergic rhinitis.

Full description

During the pollen season children with seasonal allergic rhinitis without concomitant asthma are at risk of having allergic inflammation in the lower respiratory tract. About 60% of children with seasonal allergic rhinitis present bronchial hyperresponsiveness and signs and symptoms of asthma.

The aim of this study is to compare the effect of montelukast and cetirizine on allergic inflammation measured by exhaled nitric oxide concentration in children with seasonal allergic rhinitis.

Enrollment

116 estimated patients

Sex

All

Ages

6 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • clinical symptoms of seasonal allergic rhinitis during last two seasons, moderate and severe according to ARIA guidelines

Exclusion criteria

  • diagnosis of bronchial asthma
  • allergy to perennial allergens
  • specific immunotherapy
  • other chronic diseases
  • tobacco smoking
  • acute respiratory tract infection
  • excluded drugs: inhaled and systemic glucocorticosteroids

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

116 participants in 4 patient groups, including a placebo group

1
Active Comparator group
Description:
monteluksat sodium
Treatment:
Drug: montelukast
2
Active Comparator group
Description:
cetirizine
Treatment:
Drug: cetirizine
3
Active Comparator group
Description:
montelukast sodium and cetirizine
Treatment:
Drug: montelukast and cetirizine
4
Placebo Comparator group
Description:
placebo
Treatment:
Drug: placebo

Trial contacts and locations

1

Loading...

Central trial contact

Violetta Ścibiorek, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems